Top 6 Questions To Ask When Evaluating A Biologics CDMO

By Abby Sorensen, Marketing Manager, Scorpius BioManufacturing

Bringing a biologic drug to market is a complex journey, and selecting the right Contract Development and Manufacturing Organization (CDMO) is pivotal to ensure the safe, timely, and cost-effective delivery of drug products. This article delves into six vital considerations when selecting a CDMO partner. From ensuring seamless communication and a genuine quality culture to gauging supply chain expertise and regulatory prowess, we navigate the key considerations for a successful partnership. This is not just about finding a manufacturer; it's about finding a true collaborator who shares your vision and can propel your groundbreaking biologic towards market with speed, safety, and efficiency.

Finding a CDMO whose structure is designed to expedite the introduction of innovative biologics to the market, with a flexible project management team and modular facility, can help overcome development hurdles and bring your treatment to patients in need. Learn how a CDMO with a commitment to quality and decades of industry experience can support a variety of clinical-scale programs.